Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
QDEL
HOLDQuidelOrtho Corporation · Healthcare · United States · $1.1B · Avg Vol: $25M/d
COMPANY DESCRIPTION
QuidelOrtho Corporation is a global diagnostic company that develops, manufactures, and markets innovative diagnostic solutions for point-of-care, laboratory, and transfusion medicine applications. Its competitive moat is built upon a broad portfolio of proprietary diagnostic platforms, extensive R&D capabilities, and established global distribution channels, particularly in infectious disease testing and clinical labs. Formed from a significant merger, QuidelOrtho is a major player offering critical diagnostic tools to healthcare systems worldwide.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 3.3B | 3.0B | 2.8B | 2.7B | -5.8% | 2.7B | 2.7B | 2.8B | 1.3% |
| EPS | 16.74 | 9.66 | -0.15 | -30.16 | -16.69 | -42.3% | -17.85 | — | — | — |
| Shares | — | 66.4M | 66.7M | 67.3M | 67.9M | +2.3% | 68.2M | — | — | — |
| Debt | — | 2.8B | 2.6B | 2.7B | 2.8B | -0.2% | 2.9B | — | — | — |
| Equity | — | 4.9B | 5.0B | 3.0B | 1.9B | -27.0% | — | — | — | — |
| Op CF | — | 885.3M | 280.2M | 83.0M | 105.2M | -50.8% | — | — | — | — |
| Inv CF | — | -1.6B | -187.6M | -149.9M | -192.7M | — | — | — | — | — |
| Fin CF | — | 252.0M | -265.8M | 48.8M | 155.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of QDEL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| QDEL | QuidelOrtho Corporation(you) | $1.1B | 48 | HOLD |
| SIBN | SI-BONE, Inc. | $737M | 43 | HOLD |
| INSP | Inspire Medical Systems, Inc. | $1.4B | 56 | HOLD |
| CERS | Cerus Corporation | $587M | 50 | HOLD |
| CTKB | Cytek Biosciences, Inc. | $576M | 41 | HOLD |
| BFLY | Butterfly Network, Inc. | $1.7B | 36 | HOLD |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.1B | 26 | SELL |
| KIDS | OrthoPediatrics Corp. | $485M | 54 | HOLD |
| NEOG | Neogen Corporation | $2.0B | 37 | HOLD |
| OFIX | Orthofix Medical Inc. | $455M | 54 | HOLD |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.6%